An MRI report mentions a Fazekas 2 score, and the first reaction is often concern. This grade indicates moderate white matter lesions in the brain, visible as hyperintensities on the images. It is not a diagnosis of a disease in itself, but an indicator that only takes on its full meaning when considered in the clinical context of each individual.
Fazekas 2 and prognosis: why the MRI score doesn’t tell the whole story
People often assume that a number on an MRI report is enough to predict how their health will develop. However, the Fazekas score is a visual assessment, not an individual prognostic tool. It classifies the severity of white matter hyperintensities into three grades, from the mildest to the most extensive.
A Fazekas 2 score indicates lesions that are beginning to merge, but their impact varies considerably from one person to another. Two patients with the same score may have very different symptoms: one may have no noticeable symptoms at all, while the other may have difficulty concentrating or walking.
Expert consensus on incidentally discovered hyperintensities also recommends against drawing prognostic conclusions from the score alone. Instead, the entire medical record is assessed: current symptoms, other abnormalities visible on the MRI, and vascular history. This overall assessment helps understand life expectancy with a Fazekas 2 score and guide care.
High blood pressure and vascular risk factors: the main factors affecting leukoaraiosis
Of all the factors that influence the progression of white matter lesions, high blood pressure is the most significant. Over time, it weakens the small arteries in the brain, encouraging hyperintensities to develop and spread.
This is known as cerebral small vessel disease. High blood pressure gradually damages the walls of these vessels, reducing the supply of oxygen and nutrients to the deeper regions of the brain. It is a slow process that often goes unnoticed for years.
Other vascular risk factors to monitor
High blood pressure is not the only factor. Other conditions can increase the risk of lesion progression:
- Diabetes, which impairs cerebral microcirculation through mechanisms similar to those seen in diabetic retinopathy or nephropathy
- Smoking, which accelerates the ageing of arterial walls and promotes chronic vascular inflammation
- High cholesterol, which contributes to atherosclerosis in medium- and small-calibre arteries
- Atrial fibrillation or other heart rhythm disorders, which can affect blood flow to the brain
Managing these risk factors will not make existing lesions disappear. Established hyperintensities generally do not regress. The aim is to slow progression to a more severe grade and preserve functional abilities.
Everyday symptoms with Fazekas 2: beyond memory
When people think of brain lesions, they immediately think of memory problems. Difficulties associated with Fazekas 2 can affect other areas too, although not everyone with this score necessarily has symptoms.
Executive functions are often affected first: planning a complex task, switching from one activity to another, or maintaining attention during a long conversation. These are not dramatic lapses in memory, but rather a slowing of information processing that becomes noticeable in demanding situations.
Walking and balance: an underestimated sign
Research links white matter lesions to changes in walking. Across groups of patients, studies have found slower walking, shorter steps and greater variability in pace. This does not occur in every individual, but it warrants assessment during neurological follow-up.
A fall in an older person with Fazekas 2 is not always simply due to clumsiness. Assessing walking and balance is an important part of follow-up, just like cognitive testing. Telling a doctor about any change in gait can help tailor care, for example by referring the person to a physiotherapist or reviewing certain medications.
Lifestyle and Fazekas 2: what really slows progression
Lesions cannot be erased, but it is possible to address the vascular factors that contribute to them. Regular physical activity is the best-documented modifiable factor. Walking for thirty minutes a day, swimming or cycling: the type of exercise matters less than doing it regularly.
Diet also plays a supporting role. Mediterranean-style diets rich in fruit, vegetables, fish and olive oil are associated in research with better overall vascular health. This is not a treatment for the lesions themselves, but it helps protect the arterial network that supplies them.
Social circumstances matter too
Social isolation and depression worsen the functional impact of white matter lesions. A person with strong social connections and regular intellectual and social stimulation may compensate better for the effects of Fazekas 2 than someone who is isolated but has the same MRI score.
Maintaining social connections and continuing activities that engage the mind (reading, board games, volunteering) is more than just general wellbeing advice. These are recognised factors that support cognitive reserve—the brain’s ability to function despite anatomical lesions.
Incidental Fazekas 2 finding: what to do
Many Fazekas 2 scores are discovered by chance during an MRI performed for another reason (migraines, dizziness, or assessment after an injury). This does not warrant panic, but it does call for a structured approach.
Consensus reported in the research recommends reviewing vascular risk factors with a healthcare professional. An incidental finding is not, by itself, a reason to automatically start antiplatelet treatment such as aspirin. The priority is to control blood pressure, manage diabetes if present, and stop smoking if applicable.
An MRI follow-up after an interval may be recommended to see whether the lesions remain stable or progress. The frequency depends on the clinical context. When risk factors are well controlled and there are no new symptoms, stable lesions are a common outcome and do not necessarily shorten life expectancy.
